Currently, there are 429.00M common shares owned by the public and among those 407.81M shares have been available to trade.
The company’s stock has a 5-day price change of 5.27% and 76.25% over the past three months. TOST shares are trading 134.06% year to date (YTD), with the 12-month market performance up to 204.85% higher. It has a 12-month low price of $13.77 and touched a high of $43.29 over the same period. TOST has an average intraday trading volume of 6.48 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 18.24%, 35.87%, and 64.53% respectively.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Institutional ownership of Toast Inc (NYSE: TOST) shares accounts for 70.02% of the company’s 429.00M shares outstanding.
It has a market capitalization of $24.49B and a beta (3y monthly) value of 1.87. The earnings-per-share (ttm) stands at -$0.13. Price movements for the stock have been influenced by the stock’s volatility, which stands at 4.02% over the week and 4.08% over the month.
Earnings per share for the fiscal year are expected to increase by 497.26%, and 45.03% over the next financial year. EPS should shrink at an annualized rate of -14.83% over the next five years, compared to -2.90% over the past 5-year period.
Looking at the support for the TOST, a number of firms have released research notes about the stock. Compass Point stated their Buy rating for the stock in a research note on November 20, 2024, with the firm’s price target at $49. Exane BNP Paribas coverage for the Toast Inc (TOST) stock in a research note released on November 20, 2024 offered a Neutral rating with a price target of $37. Cleveland Research was of a view on September 27, 2024 that the stock is Buy, while Mizuho gave the stock Outperform rating on July 18, 2024, issuing a price target of $21- $33. Wedbush on their part issued Outperform rating on May 24, 2024.
